Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Intangibles (2016 - 2025)

Mimedx's Intangibles history spans 11 years, with the latest figure at $5.9 million for Q4 2022.

  • For Q4 2022, Intangibles rose 8.71% year-over-year to $5.9 million; the TTM value through Dec 2022 reached $5.9 million, up 8.71%, while the annual FY2022 figure was $5.9 million, 8.71% up from the prior year.
  • Intangibles for Q4 2022 was $5.9 million at Mimedx, up from $5.4 million in the prior quarter.
  • Across five years, Intangibles topped out at $9.6 million in Q4 2018 and bottomed at $5.4 million in Q4 2021.
  • The 4-year median for Intangibles is $6.9 million (2019), against an average of $7.2 million.
  • The largest YoY upside for Intangibles was 8.71% in 2022 against a maximum downside of 8.71% in 2022.
  • A 4-year view of Intangibles shows it stood at $9.6 million in 2018, then fell by 17.24% to $8.0 million in 2019, then plummeted by 32.31% to $5.4 million in 2021, then rose by 8.71% to $5.9 million in 2022.
  • Per Business Quant, the three most recent readings for MDXG's Intangibles are $5.9 million (Q4 2022), $5.4 million (Q4 2021), and $8.0 million (Q3 2019).